106 Participants Needed

Hip Arthroscopy with Periacetabular Osteotomy for Hip Dysplasia

CW
LC
Overseen ByLauren Cole
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the best way to treat hip dysplasia, a condition where the hip joint doesn't fit snugly in its socket. Researchers are comparing two treatments: one group will receive a standard surgery called periacetabular osteotomy (PAO), while the other group will undergo an additional procedure called hip arthroscopy during the PAO surgery. The goal is to determine if adding hip arthroscopy leads to better outcomes. Individuals diagnosed with hip dysplasia and planning to have PAO surgery could be a good fit for this trial, especially if they have minimal or no arthritis and haven't had previous hip surgeries. As an unphased trial, this study offers a unique opportunity to contribute to understanding and improving treatment options for hip dysplasia.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these surgical techniques are safe for treating hip dysplasia?

Research has shown that periacetabular osteotomy (PAO) is generally safe and can significantly improve hip function. One study found that the Harris Hip Score, which measures hip function, increased from 48 before surgery to 96 six months after. Approximately 5.11% of patients experienced complications, but only a few required additional treatment.

For PAO combined with hip arthroscopy, studies indicate it is also well-tolerated. Complication rates range from 0% to 7.8%, similar to PAO alone. This combined procedure has demonstrated lasting improvements in hip function over five years.

Overall, both treatments are considered relatively safe and lead to positive outcomes for most patients.12345

Why are researchers excited about this trial?

Researchers are excited about combining hip arthroscopy with periacetabular osteotomy (PAO) for treating hip dysplasia because of its potential to address both joint issues and bone alignment in a single procedure. While standard treatments often focus solely on realigning the hip socket, this combination approach also allows for the direct treatment of soft tissue problems within the joint during the same surgery. This dual-action method could lead to better overall outcomes and quicker recovery times for patients by tackling multiple sources of pain and dysfunction at once.

What evidence suggests that this trial's treatments could be effective for hip dysplasia?

Research has shown that periacetabular osteotomy (PAO) effectively treats hip dysplasia. It can help prevent hip arthritis and improve hip function. In one study, patients' hip health scores improved significantly, from 48 to 96, just six months after surgery.

This trial will compare two treatment approaches: one group will receive the standard PAO, while another group will undergo PAO combined with hip arthroscopy. Previous studies have shown good results when adding hip arthroscopy, a procedure to examine the joint, to PAO. These studies found that patients experienced better outcomes with the combined procedures and encountered few complications. Both treatments have shown promising results for people with hip dysplasia.12367

Who Is on the Research Team?

Rafael J. Sierra, M.D. - Doctors and ...

Rafael Sierra, MD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for individuals aged 15-55 with hip dysplasia, specifically Developmental Dysplasia of the Hip (DDH), who are skeletally mature and have minimal or no arthritis. They must be able to undergo a preoperative MRI arthrogram of the hip. Pregnant women, those with previous hip surgeries, or patients treated for acetabular retroversion without DDH cannot participate.

Inclusion Criteria

I have hip dysplasia and am choosing surgery (PAO) for treatment.
My arthritis is mild or nonexistent.
My bones have stopped growing.
See 2 more

Exclusion Criteria

I am getting PAO surgery for hip socket misalignment without having developmental hip dysplasia.
I have had hip surgery to treat joint problems.
I have had surgery on my hip before.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo periacetabular osteotomy with or without hip arthroscopy

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after surgery

1 year
Multiple visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Periacetabular osteotomy
  • Periacetabular osteotomy with hip arthroscopy
Trial Overview The study compares two treatments for hip dysplasia: one group will receive Periacetabular Osteotomy (PAO) alone, while another group will get PAO combined with hip arthroscopy. The goal is to see which treatment leads to better outcomes in terms of joint function and pain relief.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Periacetabular osteotomyExperimental Treatment1 Intervention
Group II: Periacetabular osteotomy with hip arthroscopyActive Control1 Intervention

Periacetabular osteotomy is already approved in European Union, United States, Switzerland for the following indications:

🇪🇺
Approved in European Union as PAO for:
🇺🇸
Approved in United States as PAO for:
🇨🇭
Approved in Switzerland as PAO for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Published Research Related to This Trial

The Bernese periacetabular osteotomy (PAO) showed a high hip survival rate of 92% at 15 years post-surgery, indicating its effectiveness as a treatment for symptomatic acetabular dysplasia in 154 hips evaluated after an average of 10.3 years.
Factors such as fair or poor preoperative joint congruency and excessive postoperative femoral head coverage increased the risk of failure, while performing a concurrent head-neck osteochondroplasty reduced this risk, highlighting important considerations for surgical outcomes.
Intermediate-Term Hip Survivorship and Patient-Reported Outcomes of Periacetabular Osteotomy: The Washington University Experience.Wells, J., Schoenecker, P., Duncan, S., et al.[2022]
In a systematic review of 775 patients undergoing periacetabular osteotomy (PAO), it was found that labral tears were significantly more prevalent when evaluated with arthroscopy (84%) compared to open arthrotomy (21%), highlighting the importance of using arthroscopy for better detection of intra-articular injuries.
The study also revealed a high prevalence of chondral injuries, with 73% of acetabular and 27% of femoral chondral injuries identified during arthroscopy, suggesting that addressing these injuries may be crucial for improving patient outcomes after PAO.
The prevalence of hip labral and chondral lesions identified by method of detection during periacetabular osteotomy: arthroscopy versus arthrotomy.Redmond, JM., Gupta, A., Stake, CE., et al.[2022]
In a study of 38 males who underwent 46 Bernese periacetabular osteotomies (PAO), the incidence of clinical signs of femoroacetabular impingement (FAI) increased postoperatively, with 47.8% of hips showing positive impingement signs after surgery compared to 41.3% preoperatively.
Despite improvements in radiographic parameters and WOMAC scores indicating better function and less pain, the high rate of postoperative FAI signs suggests that PAO may not fully resolve symptoms related to hip impingement in male patients.
Bernese periacetabular osteotomy in males: is there an increased risk of femoroacetabular impingement (FAI) after Bernese periacetabular osteotomy?Ziebarth, K., Balakumar, J., Domayer, S., et al.[2021]

Citations

The favorable outcome of Bernese periacetabular osteotomy ...Currently, the Bernese PAO has been recognized as an effective surgery to prevent secondary hip osteoarthritis in patients with hip dysplasia.
Clinical Outcomes of 3D-Guided Ganz Periacetabular ...Mean preoperative Harris Hip Score (HHS) was 48, increasing to 92 at 3 months and 96 at 6 months postoperatively. At postoperative 6 months, 13 ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38407597/
Functional and radiological outcomes of periacetabular ...Minimally invasive periacetabular osteotomy is a safe procedure that provides significant functional outcome improvements following surgery at six months which ...
Short term-outcomes of periacetabular osteotomy in the ...In this cohort there was stable reduction of the hip in all but two patients (three hips), and effective pain management for this challenging ...
What Are the Indications for Reconstructive Pelvic ...Complications and short-term patient outcomes of periacetabular osteotomy for symptomatic mild hip dysplasia. Hip Int. 2017; 27:42-48.
Outcomes of computer-assisted peri-acetabular osteotomy ...Computer-assisted PAO not only improved accuracy and safety but also achieved sufficient anterior and lateral displacement to prevent the progression of DDH.
Functional and radiological outcomes of periacetabular ...A total of 5.11% of patients developed post-operative complications, with four requiring posterior column fixation. Four patients (1.12%) needed ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security